-Advertisement-
Exclusives
Glaucoma Treatment Takeaways From AAO 2019
Experts at the American Academy of Ophthalmology’s 2019 annual meeting in San Francisco discussed the latest in important second-line medication treatments for glaucoma. Two important takeaways: It appears that you can use the rho-kinase inhibitor netarsudil safely in eyes that are being treated with multiple classes of medications—up to four...
Read More-Advertisement-
-Advertisement-
-Advertisement-
Contact Info
© 2024 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved